Amblyopia (Lazy-eye) affects 3% of all population and puts the patients at risk for eventual vision loss.
Gold Standard treatment for lazy eye is placing a patch over the strong eye – an old-fashioned solution which suffers from very low compliance.
With the CureSight™ binocular treatment, children develop stereoscopic vision, which is difficult to be achieved with the monocular nature of the traditional patching treatment.
Supported by an integrated cloud platform which processes data from the CureSight™ system, the eye care provider receives a comprehensive patient vision summary. Progress reports and real-time monitoring of the child's treatment are easily accessible.
Significant improvement (p value<0.05) in visual acuity and stereoacuity from baseline to week 24
Compliance of 90% with CureSight™